IGC Pharma Inc Sustainability Reports
IGC Pharma, Inc. is a clinical-stage biotechnology company that develops novel therapeutic candidates and artificial intelligence-driven tools for the treatment of Alzheimer's disease and metabolic disorders.
Sector: Manufacturing
Country: United States
Exchange: NYSE American
LEI: 529900TIWO8H06FQC983
FIGI: BBG001SQQKX0
3 reports from 2018 to 2025
